Acacia Subsidiary Enters into License Agreement with Johnson & Johnson

Return to Medical Patents Alert Section

February 23rd, 2009

   2009 FEB 23 -- Acacia Research Corporation (Nasdaq: ACTG) announced that its Cardio Access LLC subsidiary has entered into a license agreement with Johnson & Johnson covering a 1993 patent relating to medical devices. The agreement resolves litigation that was pending in the United States District Court for the Eastern District of Texas with respect to certain Ethicon, Inc. (a Johnson & Johnson subsidiary) products.

   The technology generally relates to medical devices known as cannulae having multiple access port legs and at least one hemostatic valve, which are adapted for percutaneous insertion of various catheters into the bodies of patients. ABOUT ACACIA RESEARCH CORPORATION Acacia Research’s subsidiaries develop, acquire, and license patented technologies. Acacia Research’s subsidiaries control over 100 patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a wide variety of industries.

   Keywords: Acacia Research Corporation, Business, ETHICON GmbH, Patents, Pharmaceutical Business, Pharmaceutical Company.

   This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

Return to Medical Patents Alert Section